B4GALT1 and cancer: Since the relative abundance of galactosylation and related glycans changes steadily over time, we explored how the B4GALT1 in spleen B cells changes after cancer induction and found that the B4GALT1 in spleen B cells also increased after cancer induction (Figure 3A).